EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease

Saul Martinez-Horta iD, Jesús Perez-Perez, Rocío Perez-Gonzalez, Frederic Sampedro iD, Andrea Horta-Barba, Antonia Campolongo, Elisa Rivas-Asensio, Arnau Puig-Davi, Javier Pagonabarraga, Jaime Kulisevsky

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Saul Martinez-Horta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Hauptthemen laut MEDLINE: Huntington Disease, tau Proteins, Phenotype, Cognitive Dysfunction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Huntington's Disease Society of America: Human Biology Project, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The clinical phenotype of Huntington's disease (HD) can be very heterogeneous between patients, even when they share equivalent CAG repeat length, age, or disease burden. This heterogeneity is especially evident in terms of the cognitive profile and related brain changes. To shed light on the mechanisms participating in this heterogeneity, the present study delves into the association between Tau pathology and more severe cognitive phenotypes and brain damage in HD.

Methods

We used a comprehensive neuropsychological examination to characterize the cognitive phenotype of a sample of 30 participants with early‐to‐middle HD for which we also obtained 3 T structural magnetic resonance image (MRI) and cerebrospinal fluid (CSF). We quantified CSF levels of neurofilament light chain (NfL), total Tau (tTau), and phosphorylated Tau‐231 (pTau‐231). Thanks to the cognitive characterization carried out, we subsequently explored the relationship between different levels of biomarkers, the cognitive phenotype, and brain integrity.

Results

The results confirmed that more severe forms of cognitive deterioration in HD extend beyond executive dysfunction and affect processes with clear posterior‐cortical dependence. This phenotype was in turn associated with higher CSF levels of tTau and pTau‐231 and to a more pronounced pattern of posterior‐cortical atrophy in specific brain regions closely linked to the cognitive processes affected by Tau.

Interpretation

Our findings reinforce the association between Tau pathology, cognition, and neurodegeneration in HD, emphasizing the need to explore the role of Tau in the cognitive heterogeneity of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington Diseasetau ProteinsPhenotypeCognitive DysfunctionHumansMaleMiddle AgedFemaleAdultNeurofilament ProteinsMagnetic Resonance ImagingBiomarkersAtrophyNeuropsychological Tests

Substanzen

tau ProteinsNeurofilament ProteinsBiomarkers

Autor:innen und Institutionen

  • Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
  • European Huntington's Disease Network (EHDN).
  • Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) and Instituto de Neurociencias UMH-CSIC, Alicante, Spain.

ORCID-Profile: Saul Martinez-Horta, Frederic Sampedro

Förderung

  • Huntington's Disease Society of America: Human Biology Project
  • Instituto de Salud Carlos III

Zitieren

APA

Martinez-Horta, S., Perez-Perez, J., Perez-Gonzalez, R., Sampedro, F., Horta-Barba, A., Campolongo, A., Rivas-Asensio, E., Puig-Davi, A., Pagonabarraga, J., & Kulisevsky, J. (2024). Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52031

Vancouver

Martinez-Horta S, Perez-Perez J, Perez-Gonzalez R, Sampedro F, Horta-Barba A, Campolongo A, et al. Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52031

BibTeX
@article{MartinezHorta2024,
  author = {Martinez-Horta, Saul and Perez-Perez, Jesús and Perez-Gonzalez, Rocío and Sampedro, Frederic and Horta-Barba, Andrea and Campolongo, Antonia and Rivas-Asensio, Elisa and Puig-Davi, Arnau and Pagonabarraga, Javier and Kulisevsky, Jaime},
  title = {Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52031}
}
Kostenlos starten →